15 results on '"Simone, Nicole L."'
Search Results
2. The Cancer Microbiome: Distinguishing Direct and Indirect Effects Requires a Systemic View
- Author
-
Xavier, Joao B., Young, Vincent B., Skufca, Joseph, Ginty, Fiona, Testerman, Traci, Pearson, Alexander T., Macklin, Paul, Mitchell, Amir, Shmulevich, Ilya, Xie, Lei, Caporaso, J. Gregory, Crandall, Keith A., Simone, Nicole L., Godoy-Vitorino, Filipa, Griffin, Timothy J., Whiteson, Katrine L., Gustafson, Heather H., Slade, Daniel J., Schmidt, Thomas M., Walther-Antonio, Marina R.S., Korem, Tal, Webb-Robertson, Bobbie-Jo M., Styczynski, Mark P., Johnson, W. Evan, Jobin, Christian, Ridlon, Jason M., Koh, Andrew Y., Yu, Michael, Kelly, Libusha, and Wargo, Jennifer A.
- Abstract
The collection of microbes that live in and on the human body – the human microbiome – can impact on cancer initiation, progression, and response to therapy, including cancer immunotherapy. The mechanisms by which microbiomes impact on cancers can yield new diagnostics and treatments, but much remains unknown. The interactions between microbes, diet, host factors, drugs, and cell–cell interactions within the cancer itself likely involve intricate feedbacks, and no single component can explain all the behavior of the system. Understanding the role of host-associated microbial communities in cancer systems will require a multidisciplinary approach combining microbial ecology, immunology, cancer cell biology, and computational biology – a systems biology approach.
- Published
- 2020
- Full Text
- View/download PDF
3. Caloric restriction counteracts chemotherapy-induced inflammation and increases response to therapy in a triple negative breast cancer model
- Author
-
Simone, Brittany A., Palagani, Ajay, Strickland, Kimberly, Ko, Kevin, Jin, Lianjin, Lim, Meng Kieng, Dan, Tu D., Sarich, Mak, Monti, Daniel A., Cristofanilli, Massimo, and Simone, Nicole L.
- Abstract
ABSTRACTTriple negative breast cancer (TNBC) is a heterogeneous disease that has no available targeted therapies. Previously, we have shown that caloric restriction (CR) can augment the effects of radiation therapy in a TNBC mouse model. To build upon this, we now present data regarding the combination of chemotherapy and CR in the same 4T1 model. Chemotherapy can induce inflammation that breeds resistance to therapy. We propose CR as a mechanism to decrease chemotherapy-induced inflammation and increase efficacy of therapy. 12-week old Balb/c mice were orthotopically injected with a syngeneic triple negative breast cancer cell line (4T1) and were treated in one of six cohorts: ad lib fed (AL), 30% reduction in calorie intake (CR), cisplatin or docetaxol alone or a combination CR+cisplatin/docetaxol. Mice in the cohorts receiving chemotherapy+CR had longer overall survival (12 ± 2 days) as compared to the AL group. These mice also demonstrated less lung metastases at the final time point of in vivo imaging. In addition, downregulation of the IGF-1R and IRS signaling pathways were noted most significantly in those mice receiving combination therapy. Lastly, serum from these mice demonstrated an increase in inflammatory cytokines TNF-α and IL-1β in response to chemotherapy alone. This increase was dampened by the addition of CR. Taken together, these data suggest that while chemotherapy is effective in TNBC, it can cause inflammation, which can be a driver of resistance to therapy. This chemotherapy-induced inflammation can be reversed with the use of CR as a nontoxic adjunct to treatment.
- Published
- 2018
- Full Text
- View/download PDF
4. A Proof-of-Concept Pilot Test of a Behavioral Intervention to Improve Adherence to Dietary Recommendations for Cancer Prevention
- Author
-
Butryn, Meghan L., Hagerman, Charlotte J., Crane, Nicole T., Ehmann, Marny M., Forman, Evan M., Milliron, Brandy-Joe, and Simone, Nicole L.
- Abstract
Objectives Prevention programs that can help adults improve the quality of their diets to reduce cancer risk are needed. This Phase IIa study prospectively tested a mHealth intervention designed to improve adherence to dietary quality guidelines for cancer prevention.Methods All participants (N = 62) received nutrition education and a self-regulation skills curriculum, with a primary target of changing grocery shopping behavior. Using a randomized, factorial design, the study varied whether each of the following 4 components were added to the 20-week intervention: (1) location-triggered app messaging, delivered when individuals arrived at grocery stores, (2) reflections on benefits of change, delivered with extra coaching time and tailored app messages, (3) coach monitoring, in which food purchases were digitally monitored by a coach, and (4) involvement of a household member in the intervention.Results Benchmarks were successfully met for recruitment, retention, and treatment acceptability. Across conditions, there were significant reductions in highly processed food intake (P< .001, η2= .48), red and processed meat intake (P< .001, η2= .20), and sugar-sweetened beverage intake (P= .008, η2= .13) from pre-to post-treatment. Analyses examining whether each intervention component influenced change across time found that participants who received coach monitoring increased their intake of fruits, vegetables, and fiber, whereas those with no coach monitoring had less improvement (P= .01, η2= .14). The improvement in red and processed meat was stronger among participants with household support ON, at a marginally significant level, than those with household support OFF (P= .056, η2= .07).Conclusion This study showed feasibility, acceptability, and preliminary signals of efficacy of a remotely delivered intervention to facilitate adherence to dietary guidelines for cancer prevention and that coach monitoring and household support may be especially effective strategies. A fully powered clinical trial is warranted to test an optimized version of the intervention that includes nutrition education, self-regulation skills training, coach monitoring, and household member involvement.Trial Registration ClinicalTrials.govNCT04947150.
- Published
- 2023
- Full Text
- View/download PDF
5. Caloric restriction coupled with radiation decreases metastatic burden in triple negative breast cancer
- Author
-
Simone, Brittany A., Dan, Tu, Palagani, Ajay, Jin, Lianjin, Han, Sunny Y., Wright, Christopher, Savage, Jason E., Gitman, Robert, Lim, Meng Kieng, Palazzo, Juan, Mehta, Minesh P., and Simone, Nicole L.
- Abstract
ABSTRACTPurpose: Metastatic breast cancer is devastating and triple negative breast cancers (TNBC) have a higher propensity for metastasis. Improved local control upfront in this aggressive cancer could potentially decrease its propensity toward metastasis. We sought to determine if using caloric restriction (CR) as a systemic therapy, combined with radiation therapy (IR) to the primary tumor, may impact metastatic disease. Methods: An orthotopic mouse model using a highly metastatic, luciferase-tagged TNBC cell line (4T1), was used to generate palpable tumors. Mice were then treated with CR, IR, and a combination of the two. In vivoimaging was performed for metastatic evaluation. Molecular evaluation of the tumors was performed, generating a mechanistic hypothesis for CR, which was then tested with pertinent pathway inhibition in the model. Results: CR significantly increased the time to developing metastases, decreased the overall number and volume of lung metastases, and increased survival. CR decreased proliferation, increased apoptosis and globally downregulated the IGF-1R signaling pathway. Adding an IGF-1R/INSR inhibitor to local IR in vivoaccomplished a decrease in metastases similar to CR plus IR, demonstrating the importance of the IGF-1R signaling pathway, and underscoring it as a possible mechanism for CR. Conclusions: CR decreased metastatic burden and therefore may complement cytotoxic therapies being used in the clinical setting for metastatic disease. Downregulation of the IGF-1R pathway, is in part responsible for this response and modulating IGF-1R directly resulted in similar improved progression-free survival. The novel use of CR has the potential to enhance clinical outcomes for patients with metastatic breast cancer.
- Published
- 2016
- Full Text
- View/download PDF
6. Obesity and tumor growth: inflammation, immunity, and the role of a ketogenic diet
- Author
-
Wright, Christopher and Simone, Nicole L.
- Published
- 2016
- Full Text
- View/download PDF
7. Caloric restriction augments radiation efficacy in breast cancer
- Author
-
Saleh, Anthony, Simone, Brittany, Palazzo, Juan, Savage, Jason E., Sano, Yuri, Dan, Tu, Jin, Lianjin, Champ, Colin, Zhao, Shuping, Lim, Meng, Sotgia, Frederica, Camphausen, Kevin, Pestell, Richard, Mitchell, James, Lisanti, Michael, and Simone, Nicole L.
- Abstract
Dietary modification such as caloric restriction (CR) has been shown to decrease tumor initiation and progression. We sought to determine if nutrient restriction could be used as a novel therapeutic intervention to enhance cytotoxic therapies such as radiation (IR) and alter the molecular profile of triple-negative breast cancer (TNBC), which displays a poor prognosis. In two murine models of TNBC, significant tumor regression is noted with IR or diet modification, and a greater regression is observed combining diet modification with IR. Two methods of diet modification were compared, and it was found that a daily 30% reduction in total calories provided more significant tumor regression than alternate day feeding. At the molecular level, tumors treated with CR and IR showed less proliferation and more apoptosis. cDNA array analysis demonstrated the IGF-1R pathway plays a key role in achieving this physiologic response, and multiple members of the IGF-1R pathway including IGF-1R, IRS, PIK3ca and mTOR were found to be downregulated. The innovative use of CR as a novel therapeutic option has the potential to change the biology of tumors and enhance the opportunity for clinical benefit in the treatment of patients with TNBC.
- Published
- 2013
- Full Text
- View/download PDF
8. MicroRNA-203 regulates caveolin-1 in breast tissue during caloric restriction
- Author
-
Ørom, Ulf Andersson, Lim, Meng K., Savage, Jason E., Jin, Lianjin, Saleh, Anthony D., Lisanti, Michael P., and Simone, Nicole L.
- Abstract
Caloric restriction has been shown to increase lifespan in several organisms and to delay onset of age-related diseases. The transcriptional response to caloric restriction has been studied for mRNAs, while the microRNA signature following caloric restriction remains unexplored. Here, we characterize the microRNA expression in mouse breast tissue before and after caloric restriction, reporting several changes in the microRNA expression profile. In particular, miR-203 is found to be highly induced by caloric restriction, and we demonstrate that caveolin-1 as well as p63 are direct targets of miR-203 in vivo during caloric restriction. Using tissue culture models, we suggest that this regulation is important in both mouse and human. In conclusion, we show that the microRNA response induced by caloric restriction can regulate important factors in processes such as longevity and aging and is an integral and important component of the cellular response to caloric restriction.
- Published
- 2012
- Full Text
- View/download PDF
9. Proteomic evaluation of archival cytologic material using SELDI affinity mass spectrometry: potential for diagnostic applications.
- Author
-
Fetsch, Patricia A, Simone, Nicole L, Bryant-Greenwood, Peter K, Marincola, Francesco M, Filie, Armando C, Petricoin, Emmanuel F, Liotta, Lance A, and Abati, Andrea
- Abstract
Proteomic studies of cells via surface-enhanced laser desorption/ionization spectrometry (SELDI) analysis have enabled rapid, reproducible protein profiling directly from crude samples. We applied this technique to archival cytology material to determine whether distinct, reproducible protein fingerprints could be identifiedfor potential diagnostic purposes in blinded specimens. Rapid Romanowsky-stained cytocentrifuged specimens from fine-needle aspirates of metastatic malignant melanoma (with both known cutaneous primary and unknown primary sites), clear cell sarcoma, and renal cell carcinoma and reactive effusions were examined using the SELDI technology. A unique characteristic fingerprint was identified for each disease entity. Fifteen "blinded" unknown samples then were analyzed. When the protein profilefingerprints were plotted against the known fingerprints for the aforementioned diagnoses, the appropriate match or diagnosis was obtained in 13 (87%) of 15 cases. These preliminary findings suggest a substantial potential for SELDI applications to specific pathologic diagnoses.
- Published
- 2002
- Full Text
- View/download PDF
10. Sensitive Immunoassay of Tissue Cell Proteins Procured by Laser Capture Microdissection
- Author
-
Simone, Nicole L., Remaley, Alan T., Charboneau, Lu, Petricoin, Emmanuel F., Glickman, Janice W., Emmert-Buck, Michael R., Fleisher, Thomas A., and Liotta, Lance A.
- Abstract
Coupling laser capture microdissection (LCM) with sensitive quantitative chemiluminescent immunoassays has broad applicability in the field of proteomics applied to normal, diseased, or genetically modified tissue. Quantitation of the number of prostate-specific antigen (PSA) molecules/cell was conducted on human prostate tissue cells procured by LCM from fixed and stained frozen sections. Under direct microscopic visualization, laser shots 30 μm in diameter captured specific cells from the heterogeneous tissue section onto a polymer transfer surface. The cellular macromolecules from the captured cells were solubilized in a microvolume of extraction buffer and directly assayed using an automated (1.5 hour) sandwich chemiluminescent immunoassay. Calibration of the chemiluminescent assay was conducted by developing a standard curve using known concentrations of PSA. After the sensitivity, precision, and linearity of the chemiluminescent assay was verified for known numbers of solubilized microdissected tissue cells, it was then possible to calculate the number of PSA molecules per microdissected tissue cell for case samples. In a study set of 20 cases, using 10 replicate samples of 100 laser shots per sample, the within-run (intraassay) SD was approximately 10% of the mean or less for all cases. In this series the number of PSA molecules per microdissected tissue cell ranged from 2 × 104to 6.3 × 106in normal epithelium, prostate intraepithelial neoplasia (PIN), and invasive carcinoma. Immunohistochemical staining of human prostate for PSA was compared with the results of the soluble immunoassay for the same prostate tissue section. Independent qualitative scoring of anti-PSA immunohistochemical staining intensity paralleled the LCM quantitative immunoassay for each tissue subpopulation and verified the heterogeneity of PSA content between tissue subpopulations in the same case. Extraction buffers were successfully adapted for both secreted and membrane-bound proteins. This technology has broad applicability for the quantitation of protein molecules in pure populations of tissue cells.
- Published
- 2000
- Full Text
- View/download PDF
11. Rapid protein display profiling of cancer progression directly from human tissue using a protein biochip <FNR HREF="fn1"></FNR><FN ID="fn2">Questions concerning the Ciphergen SELDI instrumentation should be directed to Tai-Tung Yip, Ciphergen Biosystems, Inc., Palo Alto, CA.</FN>
- Author
-
Paweletz, Cloud P., Gillespie, John W., Ornstein, David K., Simone, Nicole L., Brown, Monica R., Cole, Kristina A., Wang, Quan-Hong, Huang, Jing, Hu, Nan, Yip, Tai-Tung, Rich, William E., Kohn, Elise C., Linehan, W. Marston, Weber, Thomas, Taylor, Phil, Emmert-Buck, Mike R., Liotta, Lance A., and Petricoin, Emanuel F.
- Abstract
The complicated, changing pattern of protein expression should contain important information about the pathologic process taking place in the cells of actual tissue. Utilization of this information for the selection of druggable targets could be possible if a means existed to rapidly analyze and display changes in protein expression in defined microscopic cellular subpopulations. As a demonstration of feasibility, we show the generation of sensitive, rapid, and reproducible molecular weight protein profiles of patient-matched normal, premalignant, malignant, and metastatic microdissected cell populations from stained human esophageal, prostate, breast, ovary, colon, and hepatic tissue sections through the application of an affinity-based biochip. Reproducible, discriminatory protein biomarker profiles can be obtained from as few as 25 cells in less than 5 min from dissection to the generation of the protein fingerprint. Furthermore, these protein pattern profiles reveal reproducible changes in expression as cells undergo malignant transformation, and are discriminatory for different tumor types. Consistent protein changes were identified in the microdissected cells from patient-matched tumor and normal epithelium from eight out of eight different malignant esophageal tissue sets and three out of three malignant prostate tissue sets. A means to rapidly generate a display of expressed proteins from microscopic cellular populations sampled from tissue could be an important enabling technology for pharmacoproteomics, molecular pathology, drug intervention strategies, therapeutic assessment of drug entities, disease diagnosis, toxicity, and gene therapy monitoring. Drug Dev. Res. 49:3442, 2000. Published 2000 Wiley-Liss, Inc.
- Published
- 2000
- Full Text
- View/download PDF
12. Laser Capture Microdissection: Beyond Functional Genomics to Proteomics
- Author
-
Simone, Nicole L., Paweletz, Cloud P., Charboneau, Lu, Petricoin, Emanuel F., and Liotta, Lance A.
- Abstract
Proteomics will drive biology and medicine beyond genomics, and can have a profound impact on molecular diagnostics. The posttranslational modifications of cellular proteins that govern physiology and become deranged in disease cannot be accurately portrayed by gene expression alone. Consequently, new technology is being developed to discover, and quantitatively monitor, proteomic changes that are associated with disease etiology and progression. In the past, proteomic technologies were restricted to tumor cell lines or homogenized bulk tissue specimens. This source material may not accurately reflect molecular events taking place in the specific cells of the tissue itself. This article describes a completely new class of proteomic-based approaches aimed at the identification and investigation of protein markers in the actual histologically defined cell populations that are immersed in heterogeneous diseased tissue. It is envisioned that these investigations will eventually lead to novel diagnostic, prognostic, or therapeutic markers that can be applied to monitor therapeutic toxicity or efficacy.
- Published
- 2000
- Full Text
- View/download PDF
13. Rapid protein display profiling of cancer progression directly from human tissue using a protein biochip
- Author
-
Paweletz, Cloud P., Gillespie, John W., Ornstein, David K., Simone, Nicole L., Brown, Monica R., Cole, Kristina A., Wang, Quan‐Hong, Huang, Jing, Hu, Nan, Yip, Tai‐Tung, Rich, William E., Kohn, Elise C., Linehan, W. Marston, Weber, Thomas, Taylor, Phil, Emmert‐Buck, Mike R., Liotta, Lance A., and Petricoin, Emanuel F.
- Abstract
The complicated, changing pattern of protein expression should contain important information about the pathologic process taking place in the cells of actual tissue. Utilization of this information for the selection of druggable targets could be possible if a means existed to rapidly analyze and display changes in protein expression in defined microscopic cellular subpopulations. As a demonstration of feasibility, we show the generation of sensitive, rapid, and reproducible molecular weight protein profiles of patient‐matched normal, premalignant, malignant, and metastatic microdissected cell populations from stained human esophageal, prostate, breast, ovary, colon, and hepatic tissue sections through the application of an affinity‐based biochip. Reproducible, discriminatory protein biomarker profiles can be obtained from as few as 25 cells in less than 5 min from dissection to the generation of the protein fingerprint. Furthermore, these protein pattern profiles reveal reproducible changes in expression as cells undergo malignant transformation, and are discriminatory for different tumor types. Consistent protein changes were identified in the microdissected cells from patient‐matched tumor and normal epithelium from eight out of eight different malignant esophageal tissue sets and three out of three malignant prostate tissue sets. A means to rapidly generate a display of expressed proteins from microscopic cellular populations sampled from tissue could be an important enabling technology for pharmacoproteomics, molecular pathology, drug intervention strategies, therapeutic assessment of drug entities, disease diagnosis, toxicity, and gene therapy monitoring. Drug Dev. Res. 49:34–42, 2000. Published 2000 Wiley‐Liss, Inc.
- Published
- 2000
- Full Text
- View/download PDF
14. Not so fast: dietary restriction improves chemotherapy-related toxicity
- Author
-
Dan, Tu D and Simone, Nicole L
- Published
- 2015
- Full Text
- View/download PDF
15. DEPARTMENT OF ERROR
- Author
-
Simone, Charles B, Simone, Nicole L, and Simone, Charles B
- Published
- 1998
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.